267 related articles for article (PubMed ID: 22127194)
1. Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.
Uher R; Mors O; Rietschel M; Rajewska-Rager A; Petrovic A; Zobel A; Henigsberg N; Mendlewicz J; Aitchison KJ; Farmer A; McGuffin P
J Clin Psychiatry; 2011 Nov; 72(11):1478-84. PubMed ID: 22127194
[TBL] [Abstract][Full Text] [Related]
2. An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.
Uher R; Tansey KE; Dew T; Maier W; Mors O; Hauser J; Dernovsek MZ; Henigsberg N; Souery D; Farmer A; McGuffin P
Am J Psychiatry; 2014 Dec; 171(12):1278-86. PubMed ID: 25017001
[TBL] [Abstract][Full Text] [Related]
3. Body weight as a predictor of antidepressant efficacy in the GENDEP project.
Uher R; Mors O; Hauser J; Rietschel M; Maier W; Kozel D; Henigsberg N; Souery D; Placentino A; Perroud N; Dernovsek MZ; Strohmaier J; Larsen ER; Zobel A; Leszczynska-Rodziewicz A; Kalember P; Pedrini L; Linotte S; Gunasinghe C; Aitchison KJ; McGuffin P; Farmer A
J Affect Disord; 2009 Nov; 118(1-3):147-54. PubMed ID: 19269691
[TBL] [Abstract][Full Text] [Related]
4. Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP.
Keers R; Uher R; Gupta B; Rietschel M; Schulze TG; Hauser J; Skibinska M; Henigsberg N; Kalember P; Maier W; Zobel A; Mors O; Kristensen AS; Kozel D; Giovannini C; Mendlewicz J; Kumar S; McGuffin P; Farmer AE; Aitchison KJ
J Affect Disord; 2010 Dec; 127(1-3):337-42. PubMed ID: 20609482
[TBL] [Abstract][Full Text] [Related]
5. Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline.
Uher R; Dernovsek MZ; Mors O; Hauser J; Souery D; Zobel A; Maier W; Henigsberg N; Kalember P; Rietschel M; Placentino A; Mendlewicz J; Aitchison KJ; McGuffin P; Farmer A
J Affect Disord; 2011 Jul; 132(1-2):112-20. PubMed ID: 21411156
[TBL] [Abstract][Full Text] [Related]
6. Non-random dropout and the relative efficacy of escitalopram and nortriptyline in treating major depressive disorder.
Power RA; Muthén B; Henigsberg N; Mors O; Placentino A; Mendlewicz J; Maier W; McGuffin P; Lewis CM; Uher R
J Psychiatr Res; 2012 Oct; 46(10):1333-8. PubMed ID: 22770672
[TBL] [Abstract][Full Text] [Related]
7. Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial.
Kok RM; Nolen WA; Heeren TJ
Int J Geriatr Psychiatry; 2007 Dec; 22(12):1247-54. PubMed ID: 17562523
[TBL] [Abstract][Full Text] [Related]
8. Estimating dose-response for time to remission with instrumental variable adjustment: the obscuring effects of drug titration in Genome Based Therapeutic Drugs for Depression Trial (GENDEP): clinical trial data.
Hellier J; Emsley R; Pickles A
Trials; 2020 Jan; 21(1):10. PubMed ID: 31900198
[TBL] [Abstract][Full Text] [Related]
9. Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder.
Köhler-Forsberg O; Larsen ER; Buttenschøn HN; Rietschel M; Hauser J; Souery D; Maier W; Farmer A; McGuffin P; Aitchison KJ; Uher R; Mors O
Br J Psychiatry; 2019 Aug; 215(2):494-501. PubMed ID: 30698114
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder.
Colonna L; Andersen HF; Reines EH
Curr Med Res Opin; 2005 Oct; 21(10):1659-68. PubMed ID: 16238906
[TBL] [Abstract][Full Text] [Related]
11. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
[TBL] [Abstract][Full Text] [Related]
12. Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms.
Uher R; Perlis RH; Henigsberg N; Zobel A; Rietschel M; Mors O; Hauser J; Dernovsek MZ; Souery D; Bajs M; Maier W; Aitchison KJ; Farmer A; McGuffin P
Psychol Med; 2012 May; 42(5):967-80. PubMed ID: 21929846
[TBL] [Abstract][Full Text] [Related]
13. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
Favré P
Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
[TBL] [Abstract][Full Text] [Related]
14. Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report.
Sung SC; Wisniewski SR; Balasubramani GK; Zisook S; Kurian B; Warden D; Trivedi MH; Rush AJ;
Psychol Med; 2013 May; 43(5):945-60. PubMed ID: 23228340
[TBL] [Abstract][Full Text] [Related]
15. Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline.
Joyce PR; Mulder RT; Luty SE; Sullivan PF; McKenzie JM; Abbott RM; Stevens IF
Aust N Z J Psychiatry; 2002 Jun; 36(3):384-91. PubMed ID: 12060188
[TBL] [Abstract][Full Text] [Related]
16. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
Blier P; Gobbi G; Turcotte JE; de Montigny C; Boucher N; Hébert C; Debonnel G
Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
[TBL] [Abstract][Full Text] [Related]
18. Placebo response and antidepressant response.
Alexopoulos GS; Kanellopoulos D; Murphy C; Gunning-Dixon F; Katz R; Heo M
Am J Geriatr Psychiatry; 2007 Feb; 15(2):149-58. PubMed ID: 17272735
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of reboxetine compared with citalopram: a double-blind study in patients with major depressive disorder.
Langworth S; Bodlund O; Agren H
J Clin Psychopharmacol; 2006 Apr; 26(2):121-7. PubMed ID: 16633139
[TBL] [Abstract][Full Text] [Related]
20. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
